# Considerations on the Development of Therapeutics in Vascular Calcification

## TL;DR

This paper reviews vascular calcification, its causes, and considerations for developing treatments to reduce cardiovascular risk.

## Contribution

The paper provides a comprehensive review of mechanisms and therapeutic considerations for vascular calcification.

## Key findings

- Vascular calcification is a major predictor of cardiovascular mortality.
- Both medial and intimal calcification involve osteogenic differentiation of smooth muscle cells.
- Therapeutic strategies must consider calcification morphology and location for effectiveness.

## Abstract

Cardiovascular disease is the leading cause of death worldwide. Vascular calcification, the deposition of calcium phosphate mineral in the arterial wall, is the most significant predictor of morbidity and mortality. Vascular calcification can present as either medial or intimal calcification. Medial calcification is most prevalent among patients with chronic kidney disease. Intimal calcification is associated with atherosclerosis and chronic inflammation. In both cases, vascular smooth muscle cells undergo osteogenic differentiation, leading to mineral deposition and associated wall stiffening; however, the effects on cardiovascular function and morbidity vary depending on mineral morphology and location. This review investigates vascular calcification, the mechanisms leading to calcium deposition, and what to consider when developing therapeutics for vascular calcification.